硫酸镁与钙通道阻滞药作为急性有机磷杀虫剂中毒解毒剂的系统评价与Meta分析
该研究系统检索了PubMed与中国学术期刊全文数据库,纳入5项临床前研究、9项病例报告或小系列、8项临床研究(含3项未发表试验),全部为有机磷杀虫剂中毒,无氨基甲酸酯类研究。汇总8项临床研究共441例患者(硫酸镁组239例,对照组202例),硫酸镁组病死率合并OR为0.55(95%CI 0.32-0.94),需插管通气的合并OR为0.52(95%CI 0.34-0.79)。但高质量III期随机对照试验结果异质性大且估计更保守,未见剂量效应;随机对照试验中接受最高剂量硫酸镁者11.1%因低血压需停止输注。结论认为现有证据不足以推荐使用硫酸镁或钙通道阻滞药,需开展大型多中心随机对照试验。
要点
- 8项临床研究共441例有机磷杀虫剂中毒患者,硫酸镁组239例 vs 对照组202例,病死率合并OR 0.55(95%CI 0.32-0.94)。
- 硫酸镁组需插管通气的合并OR为0.52(95%CI 0.34-0.79)。
- 高质量III期随机对照试验结果异质性大,提供更保守的估计,研究间未见剂量效应证据。
- 随机对照试验中接受最高剂量硫酸镁者11.1%因低血压需停止输注,不良事件报告少见。
- 临床前研究显示钙通道阻滞药在有机磷暴露前或暴露后尽早给予(联合阿托品和/或肟类)可降低死亡率;硫酸镁可减轻猪模型的胆碱能刺激与高血压,但在一项大鼠研究中进一步抑制了血清丁酰胆碱酯酶活性。
适用人群与场景
- 急性有机磷杀虫剂自服中毒患者(临床研究部分),以及暴露于有机磷或氨基甲酸酯杀虫剂的动物(临床前研究部分);未检索到氨基甲酸酯类中毒的研究。
研究设计与关键结果
- 研究类型:系统评价与Meta分析,检索PubMed与中国学术期刊全文(医药卫生系列)数据库,初筛2262篇,最终纳入19篇相关文献(5项临床前研究、9项病例报告或小系列、5项临床研究与试验),另获得3项未发表硫酸镁临床试验原始数据,共8项临床研究与试验进入分析。
- 全部研究均为有机磷杀虫剂中毒,未发现氨基甲酸酯类研究;未发现钙通道阻滞药与硫酸镁联合使用的临床前或临床研究。
- 8项临床研究中仅4项为随机对照试验;所有研究均为硫酸镁,样本量小至中等,偏倚风险高。
- 共441例患者,硫酸镁组239例,对照组202例;硫酸镁对病死率的合并OR为0.55(95%CI 0.32-0.94),对需插管通气的合并OR为0.52(95%CI 0.34-0.79)。
- 高质量III期随机对照试验结果存在异质性,提供更保守的估计;一项小剂量爬坡研究提示较高剂量硫酸镁可能获益,但研究间无剂量效应证据。
- 随机对照试验中接受最高剂量硫酸镁的患者11.1%因低血压需停止输注;不良事件报告少见。
- 临床前研究:两项啮齿类研究提示,在有机磷暴露前或暴露后尽早给予钙通道阻滞药(联合阿托品和/或肟类)可降低死亡率;中毒小型猪中硫酸镁可减轻胆碱能刺激与高血压;一项大鼠研究中硫酸镁进一步抑制了血清丁酰胆碱酯酶活性。
- 观察性临床研究:钙通道阻滞药与硫酸镁曾被用于治疗有机磷中毒患者的心律失常与高张力性子宫收缩;一项小型神经生理学研究报道硫酸镁可逆转有机磷杀虫剂暴露的神经肌肉接头效应。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析,纳入临床前研究、病例报告或小系列、临床研究与试验(含随机对照试验)。
- 8项临床研究中仅4项为随机对照试验,所有研究均为硫酸镁,样本量小至中等,偏倚风险高。
- 高质量III期随机对照试验结果存在异质性,提供更保守的估计。
- 作者结论:临床前与临床数据提示硫酸镁与钙通道阻滞药可能是有前景的辅助治疗,但现有证据不足以推荐使用;需开展机制研究及大型多中心随机对照试验,并仔细鉴定所摄入杀虫剂种类、测定包括丁酰胆碱酯酶活性在内的毒性替代标志物。
对床旁实践的改变
- 作者认为硫酸镁与钙通道阻滞药可能是有前景的辅助治疗,但现有证据不足以推荐其用于急性有机磷杀虫剂中毒。
- 随机对照试验中接受最高剂量硫酸镁者11.1%因低血压需停止输注,使用时应监测血压。
- 作者建议开展机制研究及大型多中心随机对照试验,并仔细鉴定所摄入杀虫剂种类、测定包括丁酰胆碱酯酶活性在内的毒性替代标志物。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Treatment of acute organophosphorus or carbamate insecticide self-poisoning is often ineffective, with tens of thousands of deaths occurring every year. Researchers have recommended the addition of magnesium sulfate or calcium channel blocking drugs to standard care to reduce acetylcholine release at cholinergic synapses.
OBJECTIVE: We aimed to review systematically the evidence from preclinical studies in animals exposed to organophosphorus or carbamate insecticides concerning the efficacy of magnesium sulfate and calcium channel blocking drugs as therapy compared with placebo in reducing mortality or clinical features of poisoning. We also systematically reviewed the evidence from clinical studies in patients self-poisoned with organophosphorus or carbamate insecticides concerning the efficacy of magnesium sulfate and calcium channel blocking drugs as therapy compared with placebo, in addition to standard therapy, in reducing mortality, atropine requirement, need for intubation and ventilation, and intensive care unit and hospital stay.
METHODS: We performed a systematic review for articles on magnesium sulfate and calcium channel blocking drugs in organophosphorus or carbamate insecticide poisoning using PubMed and China Academic Journals Full-text (Medicine/Hygiene Series) databases and keywords: "organophosphorus or organophosphate poisoning", "cholinesterase inhibitor poisoning" OR "carbamate poisoning" AND "magnesium", "calcium channel blocker", or generic names of different calcium channel blocking drugs. Review of titles and abstracts revealed 2262 papers of potential relevance. After review of the full papers, a total of 19 papers relevant to the question were identified: five preclinical studies, nine case reports or small case series, and five clinical studies and trials. We also obtained primary data from three unpublished clinical trials of magnesium sulfate, providing data from a total of eight clinical studies and trials for analysis. All studies were of organophosphorus insecticides; no studies of carbamates were found. No pre-clinical or clinical studies of calcium channel blocking drugs and magnesium sulfate in combination were found. We extracted data on study type, treatment regimens, outcome, and side effects. Pre-clinical studies: Two rodent studies indicated a benefit of calcium channel blocking drugs treatment on mortality if given before or soon after organophosphorus exposure, in addition to atropine and/or oxime. In poisoned minipigs, treatment with magnesium sulfate after organophosphorus insecticide poisoning reduced cholinergic stimulation and hypertension. Of note, magnesium sulfate further suppressed serum butyrylcholinesterase activity in one rat study. Observational clinical studies: Calcium channel blocking drugs and magnesium sulfate have been used to treat cardiac dysrhythmias and hypertonic uterine contractions in organophosphorus poisoned patients. A small neurophysiological study of magnesium sulfate reported reversion of neuromuscular junction effects of organophosphorus insecticide exposure. Comparative clinical studies: Only four of eight studies were randomized controlled trials; all studies were of magnesium sulfate, of small to modest size, and at substantial risk of bias. They included 441 patients, with 239 patients receiving magnesium sulfate and 202 control patients. The pooled odds ratios for magnesium sulfate for mortality and need for intubation and ventilation for all eight studies were 0.55 (95% confidence interval [CI] 0.32-0.94) and 0.52 (95% CI 0.34-0.79), respectively. However, there was heterogeneity in the results of higher quality phase III randomized controlled trials providing more conservative estimates. Although a small dose-escalation study suggested benefit from higher doses of magnesium sulfate, there was no evidence of a dose effect across the studies. Adverse effects were reported rarely, with 11.1% of patients in the randomized controlled trials receiving the highest dose of magnesium sulfate requiring their infusion to be stopped due to hypotension.
CONCLUSIONS: Both preclinical and clinical data suggest that magnesium sulfate and calcium channel blocking drugs might be promising adjunct treatments for acute organophosphorus insecticide poisoning. However, evidence is currently insufficient to recommend their use. Mechanistic and large multi-center randomized controlled trials testing calcium channel blocking drugs and magnesium sulfate are required to provide the necessary evidence, with careful identification of the insecticides ingested and measurement of surrogate markers of toxicity, including butyrylcholinesterase activity.
参考来源
- Brvar M, Chan MY, Dawson AH, et al. Magnesium sulfate and calcium channel blocking drugs as antidotes for acute organophosphorus insecticide poisoning - a systematic review and meta-analysis. Clin Toxicol (Phila). 2018. PMID: 29557685. doi:10.1080/15563650.2018.1446532
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。